135 |
Mann is up to 22,197,389 shares as of August 4th, |
CyberC |
08/07/2017 3:27:05 PM |
134 |
By 49er Before some here have their say, we have |
CyberC |
08/05/2017 11:59:13 AM |
133 |
I have invested in many pre-revenue bio techs and |
CyberC |
08/05/2017 11:35:35 AM |
132 |
Nothing but good news: For real, the technology |
CyberC |
07/31/2017 12:44:48 PM |
131 |
Regenerative Medicine: The Future of Medicine is |
CyberC |
07/31/2017 11:14:52 AM |
130 |
Share Structure Update July 31, 2017 A/S: |
CyberC |
07/31/2017 11:09:43 AM |
129 |
The Big Deal About Stem Cell Therapies and |
CyberC |
07/28/2017 11:54:34 AM |
128 |
Statement of Changes in Beneficial Ownership (4) |
CyberC |
07/27/2017 2:59:17 PM |
127 |
Beautiful volume again this morning. It is |
CyberC |
07/27/2017 10:30:47 AM |
126 |
Looks like dilution is over! Also, with Mann's |
CyberC |
07/26/2017 8:52:37 AM |
125 |
MANN TOPS 22,004,389 SHARES |
CyberC |
07/25/2017 1:41:21 AM |
124 |
Congress Could Have Major Impact on Biotech |
CyberC |
07/21/2017 4:05:06 PM |
123 |
Postponed, and as a result this is a great time |
CyberC |
07/21/2017 12:37:45 PM |
122 |
Endonovo is really needed here! One of the next |
CyberC |
07/10/2017 2:39:18 AM |
121 |
"The Use of Magnetic Field for the Reduction of |
CyberC |
07/09/2017 12:11:33 PM |
120 |
Name and Address of Reporting Person * Mann |
CyberC |
07/06/2017 12:58:28 AM |
119 |
Mann up to 21,365,349 as of |
CyberC |
07/03/2017 1:18:28 PM |
118 |
What I find interesting.... Is the CEO is |
CyberC |
07/02/2017 1:02:13 AM |
117 |
All these trials were announced long before the |
CyberC |
07/02/2017 1:01:00 AM |
116 |
Mann is up to 21,365,349 |
CyberSea |
07/01/2017 4:38:39 PM |
115 |
Endonovo Therapeutics Issues Open Letter and |
CyberSea |
07/01/2017 4:37:20 PM |
114 |
What makes ENDV Different? FYI concerning a few |
CyberC |
06/28/2017 12:15:29 AM |
113 |
Pre-Clinical Study to Determine the Effectiveness |
CyberC |
06/28/2017 12:13:21 AM |
112 |
ENDV's technology is pretty earth shattering |
CyberC |
06/28/2017 12:12:25 AM |
111 |
MANN UP TO 21,337,349 |
CyberC |
06/26/2017 4:44:58 PM |
110 |
FYI for all stock holders of ENDV.....Could this (1) |
CyberC |
06/26/2017 1:36:33 PM |
109 |
Could this be the week? LOS ANGELES, (1) |
CyberC |
06/25/2017 11:28:18 PM |
108 |
MANN MICHAEL SCOTT owns 21,294,349 10.2% Alan |
CyberC |
06/25/2017 1:04:03 PM |
107 |
DD by Homebrew ENDV was Reg SHO Threshold Flagged |
CyberC |
06/25/2017 12:50:54 PM |
106 |
The Non-Invasive Advantage of Endonovo |
CyberC |
06/25/2017 12:46:44 PM |
105 |
Endonovo Therapeutics... Unlike the other |
CyberC |
06/22/2017 9:47:17 AM |
104 |
DD: |
CyberC |
06/22/2017 9:46:05 AM |
103 |
An introduction to electromagnetic field therapy |
CyberC |
06/22/2017 9:44:28 AM |
102 |
Scott's still buying ....21,294,349 shares and |
CyberC |
06/22/2017 9:35:31 AM |
101 |
Endonovo Therapeutics... Unlike the other |
CyberC |
06/21/2017 2:32:12 PM |
100 |
Good DD is welcomed here. When looking at all the |
CyberC |
06/21/2017 8:45:49 AM |
99 |
Patent was granted before Heart Clinical was |
CyberC |
06/20/2017 7:48:05 PM |
98 |
Mann Michael Scott, President now has 21,269,349. |
CyberC |
06/20/2017 5:08:56 PM |
97 |
New Analysis... https://youtu.be/3H3JY2ImTNM It |
CyberC |
06/20/2017 2:13:28 PM |
96 |
Mann Michael Scott, President now has 21,232,349 |
CyberC |
06/19/2017 5:30:25 PM |
95 |
Endonovo at the Intersection of Stem Cells and |
CyberC |
06/19/2017 3:25:02 PM |
94 |
LOS ANGELES, CA--(Marketwired - Jun 1, 2017) - |
CyberC |
06/19/2017 12:00:26 PM |
93 |
After scanning all the OTCQB stocks, There is no |
CyberC |
06/18/2017 11:01:57 AM |
92 |
FYI, RSI changes with the interval of the time |
CyberC |
06/18/2017 10:52:02 AM |
91 |
Michael Mann has as of 6/14/2017: Common Stock |
CyberC |
06/16/2017 4:24:27 PM |
90 |
Last Year: Thursday, 10/13/16 01:02:48 PM Re: |
CyberC |
06/15/2017 12:45:44 AM |
89 |
Questions and answers to consider: Since the |
CyberC |
06/15/2017 12:32:39 AM |
88 |
Love this investment! Endonovo Therapeutics seems |
CyberC |
06/13/2017 2:33:07 PM |
87 |
Reason why to invest in Endonovo!!! Coming |
CyberC |
06/13/2017 2:32:28 PM |
86 |
ENDV likely to be around $1.25-2:50+ Q2 2018 If |
CyberC |
06/13/2017 2:30:47 PM |